The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Monocarboxylate transporters in cancer
Open accessAbstract
BACKGROUND: Tumors are highly plastic metabolic entities composed of cancer and host cells that can adopt different metabolic phenotypes. For energy production, cancer cells may use 4 main fuels that are shuttled in 5 different metabolic pathways. Glucose fuels glycolysis that can be coupled to the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS) in oxidative cancer cells or to lactic fermentation in proliferating and in hypoxic cancer cells. Lipids fuel lipolysis, glutamine fuels glutaminolysis, and lactate fuels the oxidative pathway of lactate, all of which are coupled to the TCA cycle and OXPHOS for energy production. This review focuses on the latter metabolic pathway. SCOPE OF REVIEW: Lactate, which is prominently produced by glycolytic cells in tumors, was only recently recognized as a major fuel for oxidative cancer cells and as a signaling agent. Its exchanges across membranes are gated by monocarboxylate transporters MCT1-4. This review summarizes the current knowledge about MCT structure, regulation and functions in cancer, with a specific focus on lactate metabolism, lactate-induced angiogenesis and MCT-dependent cancer metastasis. It also describes lactate signaling via cell surface lactate receptor GPR81. MAJOR CONCLUSIONS: ) animals and (MCT-mutated) humans indicate that they are druggable, with MCT1 inhibitors being in advanced development phase and MCT4 inhibitors still in the discovery phase. Imaging lactate fluxes non-invasively using a lactate tracer for positron emission tomography would further help to identify responders to the treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation
Suzuki, A., Stern, S. A., Bozdagi, O., Huntley, G. W., Walker, R. H., Magistretti, P. J., & Alberini, C. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.018 · Cited by 1,711
Deconvoluting the context-dependent role for autophagy in cancer
White, E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3262 · Cited by 1,704
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664 · cited 3×
“In genetically engineered mouse models, a full knockout of MCT1/ SLC16A1 was found to be embryonically lethal due to neuronal defects [205].”
BackgroundResultInfluentialTargeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624
Self-citationGlycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523 · cited 1×
“These results are consistent with the decreased expression of MCT1 observed in neurodegenerative human diseases, such as amyotrophic lateral sclerosis (ALS) [205,207] and Alzheimer’s disease [208], suggesting an important role of this transporter in the maintenance of axon integrity, putatively because it facilitates…”
ResultThe reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391
Lactate Metabolism in Human Lung Tumors
Faubert, B., Li, K. Y., Cai, L., Hensley, C. T., Kim, J., Zacharias, L. G., Yang, C., Do, Q. N., Doucette, S., Burguete, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.019 · Cited by 1,343
Halestrap, A. P., & Meredith, D. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1067-2 · Cited by 1,058
Cross, M. J., & Claesson-Welsh, L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01676-x · Cited by 989
Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816
Cell–cell and intracellular lactate shuttles
Brooks, G. A. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.178350 · Cited by 799
Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602235103 · Cited by 788
Evidence Supporting the Existence of an Activity-Dependent Astrocyte-Neuron Lactate Shuttle
Pellerin, L., Pellegri, G., Bittar, P. G., Charnay, Y., Bouras, C., Martin, J.-L., Stella, N., & Magistretti, P. J. (1998) · Developmental Neuroscience · doi:10.1159/000017324 · Cited by 754
The monocarboxylate transporter family—Role and regulation
Halestrap, A. P., & Wilson, M. C. (2012) · IUBMB Life · doi:10.1002/iub.572 · Cited by 741
Glutaminolysis Activates Rag-mTORC1 Signaling
Durán, R. V., Oppliger, W., Robitaille, A. M., Heiserich, L., Skendaj, R., Gottlieb, E., & Hall, M. N. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.043 · Cited by 730
The monocarboxylate transporter family—Structure and functional characterization
Halestrap, A. P. (2012) · IUBMB Life · doi:10.1002/iub.573 · Cited by 710
Kirk, P., Wilson, M. C., Heddle, C., Brown, M. H., Barclay, A. N., & Halestrap, A. P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.3896 · Cited by 700
Liu, C., Wu, J., Zhu, J., Kuei, C., Yu, J., Shelton, J., Sutton, S. W., Li, X., Yun, S. J., Mirzadegan, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806409200 · Cited by 606
Garcia, C. K., Goldstein, J. L., Pathak, R. K., Anderson, R. G. W., & Brown, M. S. (1994) · Cell · doi:10.1016/0092-8674(94)90361-1 · Cited by 587
Fiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., De Donatis, A., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 578
DIMMER, K.-S., Friedrich, B., Lang, F. J. W., Deitmer, J. W., & Bröer, S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500219 · Cited by 577
Sonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033418 · Cited by 536
Self-citationA Lactate-Induced Response to Hypoxia
Lee, D. C., Sohn, H. A., Park, Z.-Y., Oh, S., Kang, Y. K., Lee, K.-M., Kang, M., Jang, Y. J., Yang, S.-J., Hong, Y. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.011 · Cited by 520
Brooks, G. A., Dubouchaud, H., Brown, M., Sicurello, J. P., & Butz, C. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1129 · Cited by 468
Koukourakis, M. I., Giatromanolaki, A., Harris, A. L., & Sivridis, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3260 · Cited by 440
Hashimoto, T., Hussien, R., Oommen, S., Gohil, K., & Brooks, G. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8174com · Cited by 435
Le Floch, R., Chiche, J., Marchiq, I., Naiken, T., Ilc, K., Murray, C. M., Critchlow, S. E., Roux, D., Simon, M.-P., & Pouysségur, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106123108 · Cited by 429
Bourguignon, L. Y. W., Singleton, P. A., Diedrich, F., Stern, R., & Gilad, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311838200 · Cited by 422
Role of Ion Channels and Transporters in Cell Migration
Schwab, A., Fabian, A., Hanley, P. J., & Stock, C. (2012) · Physiological Reviews · doi:10.1152/physrev.00018.2011 · Cited by 420
Dhup, S., Kumar Dadhich, R., Ettore Porporato, P., & Sonveaux, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504902 · Cited by 420
Self-citationWhitaker-Menezes, D., Martinez-Outschoorn, U. E., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A. K., Birbe, R., Howell, A., Pavlides, S., Gandara, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15659 · Cited by 409
Monocarboxylate transporters in the brain and in cancer
Pérez-Escuredo, J., Van Hée, V. F., Sboarina, M., Falces, J., Payen, V. L., Pellerin, L., & Sonveaux, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.013 · Cited by 402
Self-citationLactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes
Dietl, K., Renner, K., Dettmer, K., Timischl, B., Eberhart, K., Dorn, C., Hellerbrand, C., Kastenberger, M., Kunz-Schughart, L. A., Oefner, P. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902584 · Cited by 401
Benjamin, D., Robay, D., Hindupur, S. K., Pohlmann, J., Colombi, M., El-Shemerly, M. Y., Maira, S.-M., Moroni, C., Lane, H. A., & Hall, M. N. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.043 · Cited by 401
Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1
Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., & Verma, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508718200 · Cited by 400
Doherty, J. R., Yang, C., Scott, K. E. N., Cameron, M. D., Fallahi, M., Li, W., Hall, M. A., Amelio, A. L., Mishra, J. K., Li, F., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2034 · Cited by 400
Intra- and extra-cellular lactate shuttles
BROOKS, G. A. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200004000-00011 · Cited by 383
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Polański, R., Hodgkinson, C. L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P. W., White, A., Critchlow, S. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2270 · Cited by 378
Role of monocarboxylate transporters in human cancers: state of the art
Pinheiro, C., Longatto-Filho, A., Azevedo-Silva, J., Casal, M., Schmitt, F. C., & Baltazar, F. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9428-1 · Cited by 368
Tumor metabolism: cancer cells give and take lactate
Semenza, G. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37373 · Cited by 351
Corbet, C., Pinto, A., Martherus, R., Santiago de Jesus, J. P., Polet, F., & Feron, O. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.003 · Cited by 336
Latham, T., Mackay, L., Sproul, D., Karim, M., Culley, J., Harrison, D. J., Hayward, L., Langridge-Smith, P., Gilbert, N., & Ramsahoye, B. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks066 · Cited by 333
Fox, J. E. M., Meredith, D., & Halestrap, A. P. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00285.x · Cited by 331
Cell Surface Lactate Receptor GPR81 Is Crucial for Cancer Cell Survival
Roland, C. L., Arumugam, T., Deng, D., Liu, S. H., Philip, B., Gomez, S., Burns, W. R., Ramachandran, V., Wang, H., Cruz-Monserrate, Z., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0319 · Cited by 327
Wilson, M. C., Meredith, D., Fox, J. E. M., Manoharan, C., Davies, A. J., & Halestrap, A. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411950200 · Cited by 316
Lactate-proton cotransport in skeletal muscle
Juel, C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.321 · Cited by 311
Production of Vascular Endothelial Growth Factor by Murine Macrophages
Xiong, M., Elson, G., Legarda, D., & Leibovich, S. J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65601-5 · Cited by 307
Role of GPR81 in lactate-mediated reduction of adipose lipolysis
Cai, T.-Q., Ren, N., Jin, L., Cheng, K., Kash, S., Chen, R., Wright, S. D., Taggart, A. K. P., & Waters, M. G. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.088 · Cited by 302
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300 · cited 1×
“Indeed, hypoxic adaptation is a survival mechanism that involves hypoxia-inducible transcription factors (HIFs), whereas metabolic adaptation to cell proliferation involves growth factors and their effectors, such as c-Myc and Ras, with reported overlaps [1].”
BackgroundGallagher, S. M., Castorino, J. J., Wang, D., & Philp, N. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3184 · Cited by 288
Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells
De Saedeleer, C. J., Copetti, T., Porporato, P. E., Verrax, J., Feron, O., & Sonveaux, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046571 · Cited by 277
Self-citationOvens, M. J., Davies, A. J., Wilson, M. C., Murray, C. M., & Halestrap, A. P. (2010) · Biochemical Journal · doi:10.1042/bj20091515 · Cited by 260
Pullen, T. J., da Silva Xavier, G., Kelsey, G., & Rutter, G. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01433-10 · Cited by 258
Porporato, P. E., Payen, V. L., De Saedeleer, C. J., Préat, V., Thissen, J.-P., Feron, O., & Sonveaux, P. (2012) · Angiogenesis · doi:10.1007/s10456-012-9282-0 · Cited by 255
Self-citationIncreased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
Pinheiro, C., Longatto-Filho, A., Scapulatempo, C., Ferreira, L., Martins, S., Pellerin, L., Rodrigues, M., Alves, V. A. F., Schmitt, F., & Baltazar, F. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0558-5 · Cited by 255
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
Miranda-Gonçalves, V., Honavar, M., Pinheiro, C., Martinho, O., Pires, M. M., Pinheiro, C., Cordeiro, M., Bebiano, G., Costa, P., Palmeirim, I., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos298 · Cited by 252
Hashimoto, T., Hussien, R., & Brooks, G. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00594.2005 · Cited by 250
Monocarboxylate transporter MCT1 is a target for immunosuppression
Murray, C. M., Hutchinson, R., Bantick, J. R., Belfield, G. P., Benjamin, A. D., Brazma, D., Bundick, R. V., Cook, I. D., Craggs, R. I., Edwards, S., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio744 · Cited by 248
Hewitson, K. S., Liénard, B. M. R., McDonough, M. A., Clifton, I. J., Butler, D., Soares, A. S., Oldham, N. J., McNeill, L. A., & Schofield, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608337200 · Cited by 235
Curry, J. M., Tuluc, M., Whitaker-Menezes, D., Ames, J. A., Anantharaman, A., Butera, A., Leiby, B., Cognetti, D., Sotgia, F., Lisanti, M. P., et al. (2013) · Cell Cycle · doi:10.4161/cc.24092 · Cited by 235
Philp, N. J., Ochrietor, J. D., Rudoy, C., Muramatsu, T., & Linser, P. J. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0552 · Cited by 234
Lactate promotes glutamine uptake and metabolism in oxidative cancer cells
Pérez-Escuredo, J., Dadhich, R. K., Dhup, S., Cacace, A., Van Hée, V. F., De Saedeleer, C. J., Sboarina, M., Rodriguez, F., Fontenille, M.-J., Brisson, L., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1120930 · Cited by 231 · cited 4×
“Interestingly, in cases when MCT1 inhibition increased oxidative mitochondrial metabolism, cancer cells generally became more sensitive to ETC Complex I inhibitors metformin, phenformin and his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). www.molecularmet…”
BackgroundInfluentialSelf-citationLactate Dehydrogenase B Controls Lysosome Activity and Autophagy in Cancer
Brisson, L., Bański, P., Sboarina, M., Dethier, C., Danhier, P., Fontenille, M.-J., Van Hée, V. F., Vazeille, T., Tardy, M., Falces, J., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.08.005 · Cited by 229
Self-citationMCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
Birsoy, K., Wang, T., Possemato, R., Yilmaz, O. H., Koch, C. E., Chen, W. W., Hutchins, A. W., Gultekin, Y., Peterson, T. R., Carette, J. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2471 · Cited by 228
MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4
Hong, C. S., Graham, N. A., Gu, W., Espindola Camacho, C., Mah, V., Maresh, E. L., Alavi, M., Bagryanova, L., Krotee, P. A. L., Gardner, B. K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.057 · Cited by 226
Allen, E., Miéville, P., Warren, C. M., Saghafinia, S., Li, L., Peng, M.-W., & Hanahan, D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.029 · Cited by 221 · cited 2×
“Importantly, several cancer cell lines, mostly highly glycolytic cancer cells, are not able to import and/or to oxidize lactate in normoxia [95,97,98].”
BackgroundFan, Q., Yang, L., Zhang, X., Ma, Y., Li, Y., Dong, L., Zong, Z., Hua, X., Su, D., Li, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0673-y · Cited by 216
Lactate extraction during net lactate release in legs of humans during exercise
Stanley, W. C., Gertz, E. W., Wisneski, J. A., Neese, R. A., Morris, D. L., & Brooks, G. A. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.60.4.1116 · Cited by 214
Boidot, R., Végran, F., Meulle, A., Le Breton, A., Dessy, C., Sonveaux, P., Lizard-Nacol, S., & Feron, O. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2474 · Cited by 203
Self-citationBola, B. M., Chadwick, A. L., Michopoulos, F., Blount, K. G., Telfer, B. A., Williams, K. J., Smith, P. D., Critchlow, S. E., & Stratford, I. J. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1091 · Cited by 203
Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
Pisarsky, L., Bill, R., Fagiani, E., Dimeloe, S., Goosen, R. W., Hagmann, J., Hess, C., & Christofori, G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.028 · Cited by 197
Hashimoto, T., Hussien, R., Cho, H.-S., Kaufer, D., & Brooks, G. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002915 · Cited by 196
Substrate‐induced regulation of the human colonic monocarboxylate transporter, MCT1
Cuff, M. A., Lambert, D. W., & Shirazi‐Beechey, S. P. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.014241 · Cited by 195
Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer
Kennedy, K. M., Scarbrough, P. M., Ribeiro, A., Richardson, R., Yuan, H., Sonveaux, P., Landon, C. D., Chi, J.-T., Pizzo, S., Schroeder, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075154 · Cited by 190
Self-citationWagner, W., Ciszewski, W. M., & Kania, K. D. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0114-x · Cited by 190
Monocarboxylate transporter 1 is up‐regulated in basal‐like breast carcinoma
Pinheiro, C., Albergaria, A., Paredes, J., Sousa, B., Dufloth, R., Vieira, D., Schmitt, F., & Baltazar, F. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03560.x · Cited by 189
Role of the lactate transporter (MCT1) in skeletal muscles
McCullagh, K. J., Poole, R. C., Halestrap, A. P., O'Brien, M., & Bonen, A. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.1.e143 · Cited by 189
Colen, C. B., Shen, Y., Ghoddoussi, F., Yu, P., Francis, T. B., Koch, B. J., Monterey, M. D., Galloway, M. P., Sloan, A. E., & Mathupala, S. P. (2011) · Neoplasia · doi:10.1593/neo.11134 · Cited by 187
Lactate stimulates endothelial cell migration
Beckert, S., Farrahi, F., Aslam, R. S., Scheuenstuhl, H., Königsrainer, A., Hussain, M. Z., & Hunt, T. K. (2006) · Wound Repair and Regeneration · doi:10.1111/j.1743-6109.2006.00127.x · Cited by 187
Proton channels and exchangers in cancer
Spugnini, E. P., Sonveaux, P., Stock, C., Perez-Sayans, M., De Milito, A., Avnet, S., Garcìa, A. G., Harguindey, S., & Fais, S. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.015 · Cited by 186
Self-citationCardiac and skeletal muscle mitochondria have a monocarboxylate transporter MCT1
Brooks, G. A., Brown, M. A., Butz, C. E., Sicurello, J. P., & Dubouchaud, H. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.5.1713 · Cited by 185
Izumi, H., Takahashi, M., Uramoto, H., Nakayama, Y., Oyama, T., Wang, K., Sasaguri, Y., Nishizawa, S., & Kohno, K. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01908.x · Cited by 179
miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1
Li, K. K. W., Pang, J. C.-S., Ching, A. K.-K., Wong, C. K., Kong, X., Wang, Y., Zhou, L., Chen, Z., & Ng, H.-K. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.02.003 · Cited by 178
Pértega-Gomes, N., Vizcaíno, J. R., Miranda-Gonçalves, V., Pinheiro, C., Silva, J., Pereira, H., Monteiro, P., Henrique, R. M., Reis, R. M., Lopes, C., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-312 · Cited by 178
Marchiq, I., Le Floch, R., Roux, D., Simon, M.-P., & Pouyssegur, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2260 · Cited by 175
Fang, J., Quinones, Q. J., Holman, T. L., Morowitz, M. J., Wang, Q., Zhao, H., Sivo, F., Maris, J. M., & Wahl, M. L. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026245 · Cited by 172
Wilson, M. C., Meredith, D., & Halestrap, A. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109658200 · Cited by 172
Importance of glycolysis and oxidative phosphorylation in advanced melanoma
Ho, J., de Moura, M. B., Lin, Y., Vincent, G., Thorne, S., Duncan, L. M., Hui-Min, L., Kirkwood, J. M., Becker, D., Van Houten, B., et al. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-76 · Cited by 171
Corbet, C., Draoui, N., Polet, F., Pinto, A., Drozak, X., Riant, O., & Feron, O. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0705 · Cited by 169
Pinheiro, C., Reis, R. M., Ricardo, S., Longatto-Filho, A., Schmitt, F., & Baltazar, F. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/427694 · Cited by 169
Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes
BRÖER, S., BRÖER, A., SCHNEIDER, H.-P., STEGEN, C., HALESTRAP, A. P., & DEITMER, J. W. (1999) · Biochemical Journal · doi:10.1042/bj3410529 · Cited by 169
Curtis, N. J., Mooney, L., Hopcroft, L., Michopoulos, F., Whalley, N., Zhong, H., Murray, C., Logie, A., Revill, M., Byth, K. F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18215 · Cited by 165
Noble, R. A., Bell, N., Blair, H., Sikka, A., Thomas, H., Phillips, N., Nakjang, S., Miwa, S., Crossland, R., Rand, V., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.163030 · Cited by 164
Constant, J. S., Feng, J. J., Zabel, D. D., Yuan, H., Suh, D. Y., Scheuenstuhl, H., Hunt, T. K., & Hussain, M. Z. (2000) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2000.00353.x · Cited by 163 · cited 1×
“Overall, by various mechanisms, cancer cell, endothelial cell, and/or macrophage exposure to lactate was phenotypically shown to induce endothelial cell proliferation [123,131], migration [120,121,123,131,132], tube formation [120,121,123,133], vessel sprouting from aortic explants [121], angiogenesis in the egg chori…”
BackgroundPhilp, N. J., Wang, D., Yoon, H., & Hjelmeland, L. M. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0287 · Cited by 162
Beloueche‐Babari, M., Wantuch, S., Casals, T., Koniordou, M., Parkes, H. G., Arunan, V., Chung, Y., Eykyn, T. R., Smith, P. D., & Leach, M. O. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2686 · Cited by 162
Schneiderhan, W., Scheler, M., Holzmann, K.-H., Marx, M., Gschwend, J. E., Bucholz, M., Gress, T. M., Seufferlein, T., Adler, G., & Oswald, F. (2009) · Gut · doi:10.1136/gut.2009.181412 · Cited by 161
Lee, Y. J., Shin, K. J., Park, S.-A., Park, K. S., Park, S., Heo, K., Seo, Y., Noh, D., Ryu, S. H., & Suh, P. (2016) · Oncotarget · doi:10.18632/oncotarget.12286 · Cited by 158
Endothelial cell response to lactate: Implication of PAR modification of VEGF
Kumar, V. B. S., Viji, R. I., Kiran, M. S., & Sudhakaran, P. R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20955 · Cited by 155
Deora, A. A., Philp, N. J., Hu, J. G., Bok, D., & Rodriguez-Boulan, E. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504419102 · Cited by 151
Mathupala, S. P., Parajuli, P., & Sloan, A. E. (2004) · Neurosurgery · doi:10.1227/01.neu.0000143034.62913.59 · Cited by 147
Slomiany, M. G., Grass, G. D., Robertson, A. D., Xiao, Y., Maria, B. L., Beeson, C. C., & Toole, B. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2491 · Cited by 144
Regulation of intracellular pH in human melanoma: potential therapeutic implications.
Wahl, M., Owen, J. A., Burd, R., Herlands, R., Nogami, S. S., Rodeck, U., Berd, D., Leeper, D. B., & Owen, C. S. (2002) · PubMed · Cited by 141
Lambert, D., Wood, I. S., Ellis, A., & Shirazi‐Beechey, S. P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600264 · Cited by 137
Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
Miranda‐Gonçalves, V., Granja, S., Martinho, O., Honavar, M., Pojo, M., Costa, B. M., Pires, M. M., Pinheiro, C., Cordeiro, M., Bebiano, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10114 · Cited by 136
Su, J., Chen, X., & Kanekura, T. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.07.034 · Cited by 131
Nancolas, B., Guo, L., Zhou, R., Nath, K., NELSON, D. S., Leeper, D. B., Blair, I. A., Glickson, J. D., & Halestrap, A. P. (2016) · Biochemical Journal · doi:10.1042/bj20151120 · Cited by 131
Lactate deficit in an Alzheimer disease mouse model: the relationship with neuronal damage
Zhang, M., Cheng, X., Dang, R., Zhang, W., Zhang, J., & Yao, Z. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly102 · Cited by 130 · cited 2×
“These results are consistent with the decreased expression of MCT1 observed in neurodegenerative human diseases, such as amyotrophic lateral sclerosis (ALS) [205,207] and Alzheimer’s disease [208], suggesting an important role of this transporter in the maintenance of axon integrity, putatively because it facilitates…”
BackgroundResultJiménez-Valerio, G., Martínez‐Lozano, M., Bassani, N., Vidal, A., Ochoa-de-Olza, M., Suárez, C., del Muro, X. G., Carles, J., Viñals, F., Graupera, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.015 · Cited by 129
Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport
Merezhinskaya, N., Fishbein, W. N., Davis, J. I., & Foellmer, J. W. (2000) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(200001)23:1<90::aid-mus12>3.0.co;2-m · Cited by 127
Ke, X., Fei, F., Chen, Y., Xu, L., Zhang, Z., Huang, Q., Zhang, H., Yang, H., Chen, Z., & Xing, J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs196 · Cited by 126
Zhao, Z., Wu, M.-S., Zou, C., Tang, Q., Lu, J., Liu, D., Wu, Y., Yin, J., Xie, X., Shen, J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.042 · Cited by 126
Monocarboxylate Transporter 1 Deficiency and Ketone Utilization
van Hasselt, P. M., Ferdinandusse, S., Monroe, G. R., Ruiter, J. P. N., Turkenburg, M., Geerlings, M. J., Duran, K. J., Harakaľová, M., van der Zwaag, B., Monavari, A. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407778 · Cited by 125
Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia
Philp, N. J., Yoon, H., & Lombardi, L. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.5.c1319 · Cited by 125
Quanz, M., Bender, E., Kopitz, C., Grünewald, S., Schlicker, A., Schwede, W., Eheim, A. L., Toschi, L., Neuhaus, R., Richter, C., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1253 · Cited by 124
Kim, Y., Choi, J.-W., Lee, J. H., & Kim, Y.-S. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.09.013 · Cited by 123
Huang, C.-K., Chang, P.-H., Kuo, W., Chen, C., Jeng, Y., Chang, K., Shew, J.-Y., Hu, C.-M., & Lee, W. (2017) · Nature Communications · doi:10.1038/ncomms14706 · Cited by 123
Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism
Baba, M., Inoue, M., Itoh, K., & Nishizawa, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.122 · Cited by 121
Doyen, J., Trastour, C., Ettore, F., Peyrottes, I., Toussant, N., Gal, J., Ilc, K., Roux, D., Parks, S. K., Ferrero, J.-M., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.050 · Cited by 121
Schroeder, T., Yuan, H., Viglianti, B. L., Peltz, C. D., Asopa, S., Vujašković, Ž., & Dewhirst, M. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3900 · Cited by 120
Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system?
McClelland, G. B., Khanna, S., Gonzalez, G. F., Butz, C. E., & Brooks, G. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00550-3 · Cited by 120
Payen, V. L., Hsu, M. Y., Rädecke, K. S., Wyart, E., Vazeille, T., Bouzin, C., Porporato, P. E., & Sonveaux, P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0764 · Cited by 120
Self-citationHao, J., Chen, H., Madigan, M. C., Cozzi, P. J., Beretov, J., Xiao, W., Delprado, W., Russell, P. J., & Li, Y. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605839 · Cited by 119
Xu, W., Zhang, Z., Zou, K., Cheng, Y., Yang, M., Chen, H., Wang, H., Zhao, J., Chen, P., He, L., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.60 · Cited by 117
Chiche, J., Fur, Y. L., Vilmen, C., Frassineti, F., Daniel, L., Halestrap, A. P., Cozzone, P. J., Pouysségur, J., & Lutz, N. W. (2011) · International Journal of Cancer · doi:10.1002/ijc.26125 · Cited by 116
Wilson, M. C., Meredith, D., Bunnun, C., Sessions, R. B., & Halestrap, A. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014217 · Cited by 116
Manoharan, C., Manoharan, C., Wilson, M. C., Manoharan, C., Wilson, M. C., Sessions, R. B., & Halestrap, A. P. (2006) · Molecular Membrane Biology · doi:10.1080/09687860600841967 · Cited by 114
Sprowl-Tanio, S., Habowski, A. N., Pate, K. T., McQuade, M. M., Wang, K., Edwards, R. A., Grün, F., Lyou, Y., & Waterman, M. L. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0159-3 · Cited by 109
Targeting lactate transport suppressesin vivobreast tumour growth
Morais-Santos, F., Granja, S., Miranda‐Gonçalves, V., Moreira, A. H. J., Queirós, S., Vilaça, J. L., Schmitt, F. C., Longatto‐Filho, A., Paredes, J., Baltazar, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3910 · Cited by 107
Lung cancer: An organized cellular and metabolic domain
Koukourakis, M. I., Giatromanolaki, A. N., Bougioukas, G., & Sivridis, E. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.9.4635 · Cited by 106
Saedeleer, C. J. D., Porporato, P. E., Copetti, T., Pérez‐Escuredo, J., Payen, V. L., Brisson, L., Féron, O., & Sonveaux, P. (2013) · Oncogene · doi:10.1038/onc.2013.454 · Cited by 105
Self-citationRomero-Cordoba, S. L., Rodriguez-Cuevas, S. A., Bautista‐Piña, V., Maffuz‐Aziz, A., D’Ippolito, E., Cosentino, G., Baroni, S., Iorio, M. V., & Hidalgo‐Miranda, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29708-9 · Cited by 104
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression
Sanità, P., Capulli, M., Teti, A. M., Galatioto, G. P., Vicentini, C., Chiarugi, P., Bologna, M., & Angelucci, A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-154 · Cited by 103
Pinheiro, C. M., Longatto‐Filho, A., Ferreira, L., Pereira, S. M. M., Etlinger, D., Moreira, M. A. R., Jubé, L. F., Queiroz, G. S., Schmitt, F. C., & Baltazar, F. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31817b5b40 · Cited by 103
Becker, H. M., Klier, M., Schüler, C., McKENNA, R. V., & Deitmer, J. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014293108 · Cited by 103
Galardo, M. N., Riera, M. F., Pellizzari, E. H., Cigorraga, S. B., & Meroni, S. B. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0054 · Cited by 102
The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4
Pinheiro, C. M., Miranda‐Gonçalves, V., Longatto‐Filho, A., Vicente, A. L. S. A., Berardinelli, G. N., Scapulatempo‐Neto, C., Costa, R. F. A., Viana, C. R., Reis, R. M., Baltazar, F., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1175258 · Cited by 100
Benton, C. R., Yoshida, Y., Lally, J., Han, X.-X., Hatta, H., & Bonen, A. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90217.2008 · Cited by 99
Amorim, R., Pinheiro, C. M., Miranda‐Gonçalves, V., Pereira, H., Moyer, M. P., Preto, A., & Baltazar, F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.015 · Cited by 96
Pinheiro, C. M., Longatto‐Filho, A., Simões, K., Jacob, C. E., Bresciani, C. J. C., Zilberstein, B., Cecconello, I., Alves, V. A. F., Schmitt, F. C., & Baltazar, F. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.018 · Cited by 95
Morrison, B. M., Tsingalia, A., Vidensky, S., Lee, Y., Jin, L., Farah, M. H., Lengacher, S., Magistretti, P. J., Pellerin, L., & Rothstein, J. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.10.018 · Cited by 94
Ovens, M. J., Manoharan, C., Wilson, M. C., Murray, C. M., & Halestrap, A. P. (2010) · Biochemical Journal · doi:10.1042/bj20100890 · Cited by 92
Chen, H., Wang, L., Beretov, J., Hao, J., Xiao, W., & Li, Y. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9345-9 · Cited by 92
Kong, S. C., Nøhr‐Nielsen, A., Zeeberg, K., Reshkin, S. J., Hoffmann, E. K., Novak, I., & Pedersen, S. F. (2016) · Pancreas · doi:10.1097/mpa.0000000000000571 · Cited by 92
Lengacher, S., Nehiri, T., Steiner, N., Carneiro, L., Favrod, C., Preitner, F., Thorens, B., Stehle, J., Dix, L., Pralong, F. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082505 · Cited by 90
Puig-Kröger, A., Muñiz-Pello, O., Selgas, R., Criado, G., Bajo, M.-A., Sánchez-Tomero, J. A., Alvarez, V., del Peso, G., Sánchez-Mateos, P., Holmes, C., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902451 · Cited by 87
Corbet, C., Ragelle, H., Pourcelle, V., Vanvarenberg, K., Marchand‐Brynaert, J., Véronique Préat, A., & Féron, O. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.020 · Cited by 87
Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues
Froberg, M. K., Gerhart, D. Z., Enerson, B. E., Manivel, C. J., Guzman‐Paz, M., Seacotte, N., & Drewes, L. R. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00030 · Cited by 85
MCT1 confirmed in rat striated muscle mitochondria
Butz, C. E., McClelland, G. B., & Brooks, G. A. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00009.2004 · Cited by 85
CD147 and MCT1‐potential partners in bladder cancer aggressiveness and cisplatin resistance
Afonso, J., Santos, L. L., Miranda‐Gonçalves, V., Morais, A., Amaro, T., Longatto‐Filho, A., & Baltazar, F. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22222 · Cited by 83
Inhibitory effects of statins on human monocarboxylate transporter 4
Kobayashi, M., Otsuka, Y., Itagaki, S., Hirano, T., & Iseki, K. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.043 · Cited by 81
Lemma, S., Pompo, G. D., Porporato, P. E., Sboarina, M., Russell, S., Gillies, R. J., Baldini, N., Sonveaux, P., & Avnet, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.030 · Cited by 81
Self-citationInteraction of monocarboxylate transporter 4 with β1-integrin and its role in cell migration
Gallagher, S. M., Castorino, J. J., & Philp, N. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00430.2008 · Cited by 80
MCT1 genetic polymorphism influence in high intensity circuit training: A pilot study
Cupeiro, R., Benito, P. J., Maffulli, N., Calderón, F. J., & González‐Lamuño, D. (2009) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2009.07.004 · Cited by 79
Becker, H. M., Mohebbi, N., Perna, A., Ganapathy, V., Capasso, G., & Wagner, C. A. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00488.2009 · Cited by 79
Ben-Horin, H., Tassini, M., Vivi, A., Navon, G., & Kaplan, O. (1995) · PubMed · Cited by 78
Lu, W., Huang, J., Sun, S., Huang, S., Gan, S., Xu, J., Yang, M., Xu, S., & Jiang, X. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2087-3 · Cited by 77
Lim, K. S., Lim, K. J., Price, A. C., Orr, B. A., Eberhart, C. G., & Bar, E. E. (2013) · Oncogene · doi:10.1038/onc.2013.390 · Cited by 76
Lactate Transporter Defect: A New Disease of Muscle
Fishbein, W. N. (1986) · Science · doi:10.1126/science.3775384 · Cited by 76
Colen, C. B., Seraji‐Bozorgzad, N., Marples, B., Galloway, M. P., Sloan, A. E., & Mathupala, S. P. (2006) · Neurosurgery · doi:10.1227/01.neu.0000249218.65332.bf · Cited by 76
Altered visual function in monocarboxylate transporter 3 (Slc16a8) knockout mice
Daniele, L. L., Sauer, B., Gallagher, S. M., Pugh, E. N., & Philp, N. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00124.2008 · Cited by 76
Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism
Cacace, A., Sboarina, M., Vazeille, T., & Sonveaux, P. (2017) · Oncogene · doi:10.1038/onc.2016.364 · Cited by 76
Self-citationDovmark, T. H., Saccomano, M., Hulikova, A., Alves, F., & Swietach, P. (2017) · Oncogene · doi:10.1038/onc.2017.71 · Cited by 74
Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers
Asada, K., Miyamoto, K., Fukutomi, T., Tsuda, H., Yagi, Y., Wakazono, K., Oishi, S., Fukui, H., Sügimura, T., & Ushijima, T. (2003) · Oncology · doi:10.1159/000070297 · Cited by 73
Monocarboxylate Transporters 1 and 4 Are Associated with CD147 in Cervical Carcinoma
Pinheiro, C. M., Longatto‐Filho, A., Pereira, S. M. M., Etlinger, D., Moreira, M. A. R., Jubé, L. F., Queiroz, G. S., Schmitt, F. C., & Baltazar, F. (2009) · Disease Markers · doi:10.1155/2009/169678 · Cited by 73
Zhu, J., Wu, Y., Zhang, W., Zhang, X., Ding, X., Li, H., Geng, M., Xie, Z., & Wu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087904 · Cited by 70
Differential sensitivities to lactate transport inhibitors of breast cancer cell lines
Morais-Santos, F., Miranda‐Gonçalves, V., Pinheiro, S., Vieira, A. F., Paredes, J., Schmitt, F. C., Baltazar, F., & Pinheiro, C. M. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0132 · Cited by 70
MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis
Lee, J. Y., Lee, I., Chang, W. J., Ahn, S. M., Kim, H. S., Kim, H. S., Yoo, K. H., Jung, K. S., Song, H., Cho, J. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9523 · Cited by 70
MCT1 regulates aggressive and metabolic phenotypes in bladder cancer
Zhang, G., Zhang, Y., Dong, D., Wang, F., Ma, X., Guan, F., & Sun, L. (2018) · Journal of Cancer · doi:10.7150/jca.25257 · Cited by 70
Aveseh, M., Nikooie, R., & Aminaie, M. (2015) · The Journal of Physiology · doi:10.1113/jp270463 · Cited by 69
Walenta, S., Snyder, S. A., Haroon, Z. A., Braun, R. D., Amin, K., Brizel, D. M., Mueller‐Klieser, W., Chance, B., & Dewhirst, M. W. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01700-x · Cited by 69
Gan, L., Xiu, R., Ren, P., Yue, M., Su, H., Guo, G., Xiao, D., Yu, J., Jiang, H., Liu, H., et al. (2015) · Oncogene · doi:10.1038/onc.2015.360 · Cited by 69
Martins, S. F. F., Amorim, R., Viana‐Pereira, M., Pinheiro, C. M., Costa, R. F. A., Silva, P. M. A., Couto, C., Alves, S., Fernandes, S., Vilaça, S., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2566-9 · Cited by 69
MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer
Johnson, J. M., Cotzia, P., Fratamico, R., Mikkilineni, L., Chen, J., Colombo, D., Mollaee, M., Whitaker‐Menezes, D., Domingo‐Vidal, M., Lin, Z., et al. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00027 · Cited by 68
Settle, P., Mynett, K. J., Speake, P. F., Champion, E. E., Doughty, I., Sibley, C. P., D'Souza, S. W., & Glazier, J. D. (2004) · Placenta · doi:10.1016/j.placenta.2003.11.009 · Cited by 67
A study of metabolites as intermediate effectors in angiogenesis
Murray, B., & Wilson, D. J. (2001) · Angiogenesis · doi:10.1023/a:1016792319207 · Cited by 65
Nakayama, Y., Torigoe, T., Inoue, Y., Minagawa, N., Izumi, H., Kohno, K., & Yamaguchi, K. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.361 · Cited by 65
Chenal, J., Pierre, K., & Pellerin, L. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05981.x · Cited by 62
Kim, H. K., Lee, I.-K., Bang, H., Kim, H. C., Lee, W. Y., Yun, S. H., Lee, J., Lee, S. J., Park, Y. S., Kim, K., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0535 · Cited by 60
Robinet, C., & Pellerin, L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.059 · Cited by 57
Common Responses of Tumors and Wounds to Hypoxia
Payen, V. L., Brisson, L., Dewhirst, M. W., & Sonveaux, P. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000098 · Cited by 56
Self-citationStäubert, C., Broom, O. J., & Nordström, A. (2015) · Oncotarget · doi:10.18632/oncotarget.3565 · Cited by 55
Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts
Koukourakis, M. I., Kalamida, D., Mitrakas, A. G., Liousia, M., Pouliliou, S., Sivridis, E., & Giatromanolaki, A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.79 · Cited by 54
Chenal, J., & Pellerin, L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04495.x · Cited by 53
Liu, S., Ren, C., Qu, X., Wu, X., Dong, F., Chand, Y. K., Fan, H., Yao, R., & Geng, D. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13485 · Cited by 52
Bueno, V., Binet, I., Steger, U., Bundick, R. V., Ferguson, D., Murray, C. M., Donald, D. K., & Wood, K. J. (2007) · Transplantation · doi:10.1097/01.tp.0000287543.91765.41 · Cited by 51
Ben‐Yoseph, O., Lyons, J. C., Song, C. W., & Ross, B. D. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005819604858 · Cited by 50
Zabel, D. D., Jj, F., Scheuenstuhl, H., Tk, H., & Mz, H. (1996) · PubMed · Cited by 50
Rymenant, E. V., Abrankó, L., Tumova, S., Grootaert, C., Camp, J. V., Williamson, G., & Kerimi, A. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.09.009 · Cited by 48
Nancolas, B., Sessions, R. B., & Halestrap, A. P. (2014) · Biochemical Journal · doi:10.1042/bj20141223 · Cited by 47
Bisetto, S., Whitaker‐Menezes, D., Wilski, N. A., Tuluc, M., Curry, J., Zhan, T., Snyder, C. M., Martinez‐Outschoorn, U., & Philp, N. J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00324 · Cited by 46
Characterization of monocarboxylate transporter activity in hepatocellular carcinoma
Alves, V. A. F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11780 · Cited by 45
Stromal uptake and transmission of acid is a pathway for venting cancer cell-generated acid
Hulíková, A., Black, N., Hsia, L.-T., Wilding, J. L., Bodmer, W. F., & Swietach, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610954113 · Cited by 45
Monocarboxylate transporter 1 is a key player in glioma‐endothelial cell crosstalk
Miranda‐Gonçalves, V., Bezerra, F., Costa‐Almeida, R., Freitas‐Cunha, M., Soares, R. A., Martinho, O., Reis, R. M., Pinheiro, C. M., & Baltazar, F. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22707 · Cited by 44
Cited by
The future of cancer immunotherapy: microenvironment-targeting combinations
Murciano-Goroff, Y. R., Warner, A. B., & Wolchok, J. D. (2020) · Cell Research · doi:10.1038/s41422-020-0337-2 · Cited by 749
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Lactate in the tumour microenvironment: From immune modulation to therapy
Wang, Z.-H., Peng, W.-B., Zhang, P., Yang, X.-P., & Zhou, Q. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103627 · Cited by 528
Structures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS)
Drew, D., North, R. A., Nagarathinam, K., & Tanabe, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00983 · Cited by 465
Zhou, Y., Fan, S., Feng, L., Huang, X., & Chen, X. (2021) · Advanced Materials · doi:10.1002/adma.202104223 · Cited by 463
Metadata
- Authors
- Payen, V. L., Mina, E., Van Hée, V. F., Porporato, P. E., & Sonveaux, P.
- Venue
- Molecular Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 33
- Pages
- 48-66
- ISSN
- 2212-8778 (ISSN-L)
- OpenAlex
- W2964459657
- Cited by
- 644
- References
- 230
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.